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552a Tuesday, February 18, 2014channel responsible for membrane potential control in lymphocytes, high
affinity and selectivity toxins have been used to demonstrate therapeutic
application of peptide inhibitors in vitro as well as in vivo. Margatoxin
(MgTx) is often considered as a high affinity and selective inhibitor of the
Kv1.3 channel. MgTx consists of 39 amino acids stabilized by 3 disulfide
bridges isolated from the venom of the scorpion Centruroides margaritatus.
This peptide is widely used in the area of ion channel research, often to
verify Kv1.3 expression in the plasma membrane. However, a comprehensive
study of its selectivity with electrophysiological methods has not been pub-
lished yet.
We conducted electrophysiological measurements with the patch-clamp tech-
nique in voltage clamp mode to test the selectivity of MgTx. Measurements
were carried out on L929 cells expressing mKv1.1 channels, human peripheral
lymphocytes expressing Kv1.3 channels and transiently transfected tsA201
cells with the following ion channels: hKv1.1, hKv1.2, hKv1.3, hKv1.4-IR,
hKv1.5, hKv1.6, hKv1.7, hKv2.1, Shaker-IR, hERG, hKCa1.1, hKCa3.1 and
hNav1.5.
Margatoxin is indeed a high affinity inhibitor of the Kv1.3 channel (Kd =
11.7 pM) but is not selective, since it inhibited Kv1.2 channel with similarly
high affinity (Kd = 6.4 pM) and Kv1.1 in the nanomolar range (Kd = 4.2 nM
and 1.7 nM for human and murine Kv1.1 respectively).
Based on our comprehensive data MgTX has to be considered a non-selective
Kv1.3 inhibitor, and thus, experiments aiming at elucidating the significance of
Kv1.3 in in vitro or in vivo physiological responses using MgTx need to be
carefully evaluated.
2792-Pos Board B484
Mechanisms of ATP-Sensitive Potassium Channel Overactivity in Cantu
Mutants
Paige Cooper, Monica Sala-Rabanal, Colin Nichols.
Cell Biology and Physiology, Washington University in Saint Louis, Saint
Louis, MO, USA.
In 2012 two papers were published papers drawing a connection between ge-
netic mutations in the ABCC9 gene and a disease called Cantu Syndrome.
Patients with Cantu generally present with some or all of the following:
hypertrichosis, distinct facial features, osteochndrosyplasia and cardiac defects
[1] and [2]. The ABCC9 gene, that has been associated with this disease,
encodes for a sulfonylurea receptor (SUR2), which couples with inwardly
rectifying potassium pore forming subunits (Kir6.X) to form ATP-sensitive
potassium (KATP) channels [3]. The KATP channels formed using SUR2
is expressed in two major isoforms (SUR2A and SUR2B) leading to dif-
ferential expression pattern across a variety of excitable tissues including
vascular smooth muscle[4], skeletal muscle and the heart[5] to serve as the
link between cell metabolism and electrical activity. Harakalova et al showed
some evidence for these Cantu mutations resulting in overactive KATP
channels. To address the mechanism behind these potentially over-active
mutations our lab has generated the equivalent of the documented human
mutations in ratSUR2A, a dominant isoform of SUR2. By transiently transfect-
ing COSm6 cells with kir6.2 along with P429L, A475V or C1039Y we have
studied the effect of these mutations on channels activity. Separately we
have tested both ATP-sensitivity and ADP-activation. We have found.
P429L and A475V channels ATP-sensitivity remains unchanged, but the rela-
tive ADP activation for both P429L and A475V at 56.950.06% and
59.750.11% were significantly greater than the 26.850.03% activation
in WT. The C1039Y MgADP activation is also significantly increased
38.750.04% , but in addition C1039Y channels are 1.7 fold less sensitive to
ATP. These results would suggest that while these mutations may each lead
to overactive KATP channels there are a variety of mechanisms from which
this over activity arises.
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Glucose regulation of pancreatic alpha-cell Ca2þ entry through voltage-
dependent Ca2þ channels is essential for normal glucagon secretion and
becomes defective during the pathogenesis of diabetes mellitus. The two-
pore-domain potassium (K2P) channel, TASK-1, is an important modulator
of membrane voltage and Ca2þ entry, however, its role in alpha-cells has not
been determined. Therefore, we addressed how TASK-1 channels modulate
alpha-cell electrical activity, calcium entry and glucagon secretion. We find
that TASK-1 channels are expressed in human and rodent alpha-cells. Further-more, alpha-cell K2P currents are blocked by the specific and potent TASK-1
channel inhibitor A1899. Alpha-cell K2P currents are also significantly reduced
following ablation of mouse alpha-cell TASK-1 channels. Inhibition of
TASK-1 channels with A1899 causes membrane potential depolarization in
both the human and mouse alpha-cells, which results in increased Ca2þ influx.
While A1899 augments alpha-cell Ca2þ influx under low (1 mM) and high
(14 mM) glucose conditions, treatment of mouse and human islets with
A1899 only increases glucagon secretion under elevated (14 mM) glucose con-
ditions. Therefore, these data suggest an important role for TASK-1 channels in
limiting alpha-cell excitability and glucagon secretion during glucose stimula-
tion. Interestingly, we also find that TASK-1 expression is reduced during
the progression of type-2 diabetes mellitus in human islets. Thus, decreased
TASK-1 channel activity may exacerbate the defective glucose inhibition of
glucagon secretion observed in type-2 diabetes mellitus.
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Long QT syndrome (LQTS) is an inherited disorder characterized by prolonged
QT interval in the ECG. Human and canine patients are predisposed to syncopal
episodes and sudden cardiac death (SCD). In humans mutations in 13 genes
affecting ion channel function are involved in LQTS. KCNQ1 and KCNH2
represent the molecular correlate of the slow (Iks) and fast (Ikr) repolarizing
Kþ currents in the heart and mutations in these genes are responsible for about
90% of cases. Sudden death is well known in horses and unacceptable from an
ethical, financial and safety point of view. Up to 68% of sudden deaths in race-
horses occur of unknown reasons, but are often suspected to be exercise-
induced acute cardiovascular failure. The objective of this project is to clone
and characterize the equine KCNH2 and KCNQ1 channels. This may allow
for the diagnosing of possible LQTS syndromes in horses.
To clone the channels and their regulatory subunits mRNA was isolated from
equine ventricular myocytes and full length PCR products for KCNH2,
KCNQ1, KCNE1 and KCNE2 were amplified using RACE PCR. The products
were sequenced and subcloned for expression in Xenopus oocytes. After
expression two-electrode voltage clamp was performed to characterize the elec-
trophysiological properties of the channels.
The protein sequences for the equine channels and beta-subunits were
compared with the respective human sequences and showed the following
homologies, KCNH2: 99%, KCNQ: 91%, KCNE1: 80% and KCNE2: 90%.
After expression in Xenopus oocytes, the equine KCNH2 showed electrophys-
iological properties resembling the human channel. The equine KCNQ1/KCNE
channels await thorough electrophysiological characterization.
In conclusion, it is expected that the KCNH2 and KCNQ are responsible for
repolarization of the equine heart and mutations in these proteins may lead
to yet unknown equine LQTS.
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Patient-specific induced pluripotent stem cells (iPSCs) will assist research on
genetic cardiac maladies if the disease phenotype is recapitulated in vitro.
However, genetic background variations may confound disease traits, espe-
cially for disorders with incomplete penetrance, such as long-QT syndromes
(LQTS).
To study the LQT2-associated c.A2987T (N996I) KCNH2 mutation under
genetically defined conditions, we derived iPSCs from a patient carrying
this mutation and corrected it using homologous recombination. Furthermore,
we introduced the same point mutation in human embryonic stem cells
(hESCs), generating two genetically distinct isogenic pairs of LQTS and con-
trol lines.
Correction of the mutation normalized the current (IKr) conducted by the
HERG channel and the action potential duration in iPSC-derived cardiomyo-
cytes. Introduction of the same mutation reduced IKr and prolonged the action
potential duration in hESC-derived cardiomyocytes. Further characterization
of N996I-HERG pathogenesis revealed a trafficking defect associated with
a ~30-40% reduction in IKr.
